pocketful logo light
pocketful logo light
Sanofi India Ltd logo

Sanofi India Ltd

NSE: SANOFI BSE: 500674

3352.80

(0.96%)

Tue, 25 Aug 2026, 01:34 am

Sanofi India Share Price Live Chart

1 Day

(0.96%)

No Result Found

Summary

  • Market Cap (in Cr)

    8111.74

  • Net Profit (in Cr)

    413.3

  • P/B

    16.36

  • Sector P/E

    33.76

  • P/E

    34.06

  • EV/EBITDA

    24.25

  • Debt/Equity (Industry)

    0.08

  • Interest Cover (Industry)

    42.77

  • ROCE (Industry)

    23.88

  • RONW (Industry)

    19.04

  • ROE

    47.13

  • ROCE

    47.95

  • Debt/Equity

    0.02

  • EPS (TTM)

    164.93

  • Dividend Yield

    3.49

  • Book Value

    373.70

  • Interest Cover

    313.73

Analysis

No Result Found

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersMAR 2026DEC 2025SEPT 2025JUN 2025MAR 2025
Promoters60.4060.4060.4060.4060.40
FII5.645.555.575.615.57
DII21.1321.3122.2923.0623.02
Public12.8312.7411.7410.9411.01
Government00000

Read More

Technical Analysis

RSI

45.40

MACD

-21.24

50 DMA

3355.80

200 DMA

3714.19

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic3763.433564.533441.273365.633242.373166.732967.83
Fibonacci3564.533488.553441.613365.633289.653242.713166.73
Camarilla3372.703354.473336.233365.633299.773281.533263.30

Pivots Level: Classic

R3

+397.80

3763.43

R2

+198.90

3564.53

R1

+75.63

3441.27

3365.63
3365.63
Pivot Point
LTP: 3274.60

S1

-123.27

3242.37

S2

-198.90

3166.73

S3

-397.80

2967.83

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    3291.64

  • 20-EMA

    3308.33

  • 30-EMA

    3319.45

  • 50-EMA

    3334.71

  • 100-EMA

    3432.73

  • 200-EMA

    3779.26

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
28 Apr 2026board-meetingsQuarterly Results
25 Mar 2026agm
25 Feb 2026board-meetingsAccounts, Quarterly Results, Final Dividend
25 Feb 2026dividend₹48.00 Dividend /Share22 Apr 2026
29 Oct 2025board-meetingsQuarterly Results, Nine Months Results, Interim Dividend
29 Oct 2025dividend₹75.00 Dividend /Share07 Nov 2025
07 Oct 2025dividendInterim Dividend - Rs. - 7507 Nov 2025
25 Mar 2025dividendFinal Dividend - Rs. - 11725 Apr 2025
18 Mar 2025agm
27 Feb 2025dividend₹117.00 Dividend /Share25 Apr 2025

Read More

Peer Comparison

Sanofi India Ltd logo

Sanofi India Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Cipla Ltd logo

Cipla Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Read More

Sanofi India Ltd About

Sanofi India is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has its own manufacturing facility at Goa. The Company sells its products through independent distributors primarily in India.

Industry

Pharmaceuticals - Multinational

Founded

1956

Headquarters

CEO

Rahul Bhatnagar

Employees

Contact

Website icon

Website

http://www.sanofiindialtd.com

Email icon

Email

igrc.sil@sanofi.com

Phone icon

Phone

91-22-28032000

Location icon

Location

Sanofi Hse 117-B Saki Vihar Rd, L&T Business Park Powai, Mumbai, Maharashtra, 400072

Read More

Sanofi India Ltd Company History

YearHistory
2019
  • Sanofi India partnered to reduce diabetes burden on state's health exchequer.
2020
  • Sanofi Pasteur launched VaxLine in India.
  • Sanofi India launched Allergy Free.
  • Sanofi Pasteur launched Tetraxim DTaP booster vaccine for preschoolers in India.
2021
  • Sanofi India announced sale and transfer of Nutraceuticals business to Universal Nutriscience.
  • Sanofi and GSK received approval for Phase 3 trial of COVID-19 vaccine candidate in India.
2023
  • Sanofi received marketing approval for diabetes drug Soliqua in India.
2024
  • Sanofi announced expansion of its Global Capability Centre in Hyderabad.
  • Sanofi received marketing authorization for Beyfortus in India against RSV.
  • Sanofi and Cipla announced exclusive distribution partnership for CNS portfolio in India.

Read More

Deals

Client NameDeal TypeOrder SideQTYAvg PriceDate
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy44855743.717 Oct 2022
ISHARES INDIA SC MAURITIUS COMPANYblockSell44855743.717 Oct 2022
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell388635743.717 Oct 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy388635743.717 Oct 2022
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy21805887.211 Oct 2022
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell189055887.211 Oct 2022
ISHARES INDIA SC MAURITIUS COMPANYblockSell21805887.211 Oct 2022
ISHARES CORE MSCI EMERGING MARKETS ETFblockBuy189055887.211 Oct 2022
ISHARES MSCI INDIA SMALL-CAP ETFblockBuy21775780.803 Oct 2022
ISHARES CORE EMERGING MARKETS MAURITIUS COblockSell188785780.803 Oct 2022

Read More

Sanofi India Ltd News

Sanofi India: Nakul Verma steps down as Senior Management

Sanofi India Limited discloses that Nakul Verma, Head of Public Affairs & Market Access, ceases to be Senior Management Personnel on July 31, 2026, moving to another role within the group.

31 Jul 2026

companies

Sanofi India to host Q2FY27 earnings call

Sanofi India Limited will hold an investor call on August 5, 2026, to discuss unaudited financial results for the quarter and half year ended June 30, 2026.

23 Jul 2026

companies

Sanofi India wins tax appeal

Sanofi India received a favourable order deleting a tax demand of ₹72.71 lakh for AY 2019-20. The CIT(A) ruled the company cannot be treated as an assessee in default.

03 Jul 2026

companies

Sanofi India refund claim of ₹11.62L rejected

Sanofi India's refund application of ₹11.62 lakh was rejected by the Deputy Commissioner of State GST, Ahmedabad. The company plans to appeal the order.

24 Jun 2026

companies

Sanofi India appoints Debajit Roy

Sanofi India Limited appointed Mr. Debajit Roy as Sales & Customer Engagement Head – Diabetes, effective June 8, 2026.

03 Jun 2026

companies

Read More

Open Your Free Demat Account

Enter your phone number